miRNA-155 upregulation and complement factor H deficits in Down's syndrome

Area of Science:

• Genetics
• Immunology
• Neuroscience

Background:

• Down's syndrome is a genetic disorder caused by chromosome 21 triplication, leading to cognitive impairment and Alzheimer's.
• The Down's syndrome brain exhibits activated microglia, increased inflammation, and immune system abnormalities.

Purpose of the Study:

• To investigate the role of micro-RNA 155 (miRNA-155) in the immunopathology of Down's syndrome.
• To explore the relationship between miRNA-155 and complement factor H (CFH) in Down's syndrome.

Main Methods:

• Screening of miRNA in Down's syndrome brain and peripheral tissues.
• Analyzing miRNA-155 and its target CFH levels.
• Using stressed primary human neuronal-glial cells to model the effects.
• Employing anti-miRNA-155 to reverse observed changes.

Main Results:

• An upregulation of chromosome 21-encoded miRNA-155 was observed in Down's syndrome tissues.
• A decrease in the abundance of CFH, a repressor of the innate immune response, was found.
• Stressed neuronal-glial cells showed increased miRNA-155 and decreased CFH, which was reversible with anti-miRNA-155.

Conclusions:

• A generalized miRNA-155-mediated downregulation of CFH may explain immunopathological deficits in Down's syndrome.
• This mechanism could contribute to both brain and systemic immune pathology in individuals with Down's syndrome.